Moolec Science SA

MLEC Healthcare Biotechnology

Moolec Science SA’s revenue for fiscal 2025 (year ended June 2025) was $333.6 million, up 5,830.7% from fiscal 2024.

Revenue
+948.4%
EPS
−20.0%
Free cash flow
+4.48%

Quarter to December 2025, against a year earlier

0.85 0.00 0.00%
Market cap
$620.0K
P/E
0.0×
Fwd P/E
−2.5×
Dividend yield
—
F-score
4/9
Altman Z
−1.92
Beneish M
89.08
Dividend safety
0/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '25 Jun '24 Jun '23 Jan '23 Jun '22 Dec '21 Jan '21 Dec '20 Jun '20 Jan '20
Total current assets
31.19 438.21 5.33 — 1.08 0.16 — 0.31 — 0.01
Total non-current assets
173.52 511.63 18.72 — 4.61 138.01 — 0.31 0.31 —
Total Assets
204.71 949.84 24.05 — 5.69 138.17 — 0.31 0.31 0.31
Total current liabilities
236.05 427.40 12.60 — 4.09 1.12 — 0.30 — 0.30
Total non-current liabilities
51.53 272.43 1.35 — — 140.20 — — — —
Total liabilities
287.58 699.84 13.95 — 4.09 141.31 — 0.30 — 0.30
Common Equity (Total)
(82.87) 250.00 10.11 — 1.60 (3.14) — 0.01 — 0.01
Shareholders Equity (Total)
(82.87) 250.00 10.11 — 1.60 (3.14) — 0.01 — 0.01
Total Debt
246.76 450.73 2.65 2.65 — 0.13 0.13 0.13 — 0.30

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 26 Oct 2026